Results for chop translation from Estonian to English

chop
chop

chop,
80.9

r- chop
r-chop

lamb chop drop
lamb chop drop

r- chop cr
r-chop cr

r-chop (n = 242)
r-chop (n=242)

tulemustest chop vs r- chop (keskmine
r-chop (31 months median observation time)

r-chop (vaatlusperioodi mediaan 31 kuud)
r-chop (31 months median observation time)

mabthera’t kasutatakse kombinatsioonis chop-kemoteraapiaga.
mabthera should be used in combination with chop chemotherapy.

v1 varieerus kehapinna suuruse ja chop-ravi järgi.
v1 varied by body surface area (bsa) and chop therapy.

chop 79%) ja neutropeenia (r-cvp 24% vs.
chop 79%), neutropenia (r-cvp 24% vs.

chop 88%) esinemissagedus tavaliselt suurem kui ainult kemoteraapia puhul.
chop 88%), were usually reported with higher frequencies when compared to chemotherapy alone.

lamb chop drop is a fast action skydiving game where you must control lamb ch...
lamb chop drop is a fast action skydiving game where you must control lamb ch...

36,5 kuud versus 15,1 kuud r-chop rühmas).
36.5 months versus 15.1 months in the r-chop group).

gazyvaro samaaegne manustamine ei mõjutanud bendamustiini, fc, kloorambutsiili või chop üksikkomponentide farmakokineetikat.
co-administration with gazyvaro had no effect on the pharmacokinetics of bendamustine, fc, chlorambucil or the individual components of chop.

laiaulatusliku tuumorimassiga follikulaarse lümfoomi täiendava ravimina, kombineerituna sobiva kemoteraapiaga nagu chop- taoline ravikuur.
treatment of high tumour burden follicular lymphoma as adjunct to appropriate combination induction chemotherapy such as a chop-like regimen.

r-chop ravi seostati näitajate paranemisega nii kõrge kui madala riskiga patsientide seas vastavalt ea järgi kohandatud ipi indeksile.
r-chop was associated with improvements in outcome for both high- and low-risk patients according to age adjusted ipi.

täieliku ravivastuse kestuse mediaan oli br-cap rühmas 42,1 kuud võrreldes 18 kuuga r- chop rühmas.
the median duration of complete response was 42.1 months in the br-cap group compared with 18 months in the r- chop group.

kolmel chop rühma patsiendil (1,5 %) tekkisid aga tserebrovaskulaarsed tüsistused, mis kõik ilmnesid jälgimisperioodi jooksul.
in contrast, three patients (1.5 %) had cerebrovascular events in the chop group, all of which occurred during the follow-up period.

soovitatav on kasutada chop sarnaseid raviskeeme, kuid kliiniline kogemus on kättesaadav ainult chvp kohta (kombinatsioon tsüklofosfamiidist, doksorubitsiinist, teniposiidist ja prednisoloonist).
chop -like regimens are advised, but clinical experience is available only with chvp (combination of cyclophosphamide, doxorubicin, teniposide and prednisolone).